PATOU GARY

Average Profitability
22.07%
Insider Buys Quantity
2
Insider Buys Sum
$71,676.50
Insider Sells Quantity
12
Insider Sells Sum
$20.15M

Insider Activity of PATOU GARY

According to the SEC Form 4 filings, PATOU GARY, being in a position of

  1. director at Xenon Pharmaceuticals Inc.,
    оver the last 12 months, has bought 0 shares, and sold 26576 shares for $1.07M,
    over all time since 2017-08-08, has bought 25000 shares for $71,677, and sold 28513 shares for $1.14M.

The largest purchase of all time was on 2017-08-10 and amounted to 15000 shares of Xenon Pharmaceuticals Inc. for $41,672.

The largest sale of all time was on 2014-07-14 and amounted to 59400 shares of Pacira BioSciences, Inc. for $5.17M.

Biography of PATOU GARY

No biography is available at this moment.

2023-12-14SaleXenon Pharmaceuticals Inc.
XENE
director
7,598
0.0103%
$41.05$311,898+1.47%
2023-12-13SaleXenon Pharmaceuticals Inc.
XENE
director
18,978
0.0257%
$39.99$758,983+4.83%
2022-11-25SaleXenon Pharmaceuticals Inc.
XENE
director
1,937
0.0032%
$34.79$67,390+8.16%
2017-08-10PurchaseXenon Pharmaceuticals Inc.
XENE
director
15,000
0.0842%
$2.78$41,672+28.18%
2017-08-08PurchaseXenon Pharmaceuticals Inc.
XENE
director
10,000
0.0575%
$3.00$30,005+15.95%
2014-08-07SalePacira BioSciences, Inc.
PCRX
Chief Medical Officer
40,000
0.1121%
$100.26$4.01M-7.25%
2014-07-14SalePacira BioSciences, Inc.
PCRX
Chief Medical Officer
59,400
0.1629%
$86.96$5.17M+5.09%
2014-05-12SalePacira BioSciences, Inc.
PCRX
Chief Medical Officer
20,000
0.0547%
$75.00$1.5M+20.17%
2014-05-09SalePacira BioSciences, Inc.
PCRX
Chief Medical Officer
40,000
0.1137%
$74.08$2.96M+26.39%
2013-10-01SalePacira BioSciences, Inc.
PCRX
Chief Medical Officer
40,000
0.059%
$25.27$1.01M+41.38%
2013-07-02SalePacira BioSciences, Inc.
PCRX
Chief Medical Officer
20,000
0.0599%
$30.00$600,000+88.3%
2013-07-01SalePacira BioSciences, Inc.
PCRX
Chief Medical Officer
60,000
0.1791%
$29.25$1.75M+92.36%
2013-04-12SalePacira BioSciences, Inc.
PCRX
Chief Medical Officer
20,000
0.0319%
$15.80$316,100+64.96%
2013-04-01SalePacira BioSciences, Inc.
PCRX
Chief Medical Officer
60,000
0.1788%
$28.15$1.69M+67.16%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.